meta-analysis | Q815382 |
systematic review | Q1504425 |
scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Laith J Abu-Raddad | Q37607654 |
Sarwat Mahmud | Q89490685 | ||
Vajiheh Akbarzadeh | Q123570195 | ||
P2860 | cites work | Epidemiology of hepatitis C virus infection | Q22305500 |
Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. | Q24810970 | ||
Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis | Q26745482 | ||
Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence | Q26753183 | ||
Iran's Activities on Prevention, Treatment and Harm Reduction of Drug Abuse | Q26766334 | ||
Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis | Q26768490 | ||
Epidemiology of hepatitis C virus in Iran | Q26781996 | ||
The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis | Q26784519 | ||
The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis | Q26795711 | ||
Hepatitis C Virus Genotypes in the Middle East and North Africa: Distribution, Diversity, and Patterns | Q38607430 | ||
Torque teno virus and hepatitis C virus co-infection in Iranian pediatric thalassemia patients. | Q38756951 | ||
Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006). | Q38867237 | ||
Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts | Q38904187 | ||
Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. | Q39000330 | ||
HCV burden of infection in Egypt: results from a nationwide survey | Q39035521 | ||
Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention | Q39047581 | ||
Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran | Q39452337 | ||
Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran. | Q39751130 | ||
Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran | Q39824794 | ||
Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran | Q39870377 | ||
HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran | Q39885934 | ||
Seroprevalence of hepatitis C virus: the first population-based study from Iran | Q39886309 | ||
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. | Q41041841 | ||
Risk factors of HCV seroconversion in hemodialysis patients in tabriz, iran | Q41205159 | ||
Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran | Q41274804 | ||
Global epidemiology and genotype distribution of the hepatitis C virus infection | Q27001240 | ||
HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis | Q27013667 | ||
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
Global epidemiology of hepatitis C virus infection | Q27860799 | ||
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses | Q28087794 | ||
The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study | Q28476680 | ||
Blood-borne hepatitis in opiate users in iran: a poor outlook and urgent need to change nationwide screening policy | Q28535593 | ||
Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections | Q28538968 | ||
Transformations Related to the Angular and the Square Root | Q29397126 | ||
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
Evolving epidemiology of hepatitis C virus | Q29619973 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis | Q30651560 | ||
HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran | Q33784758 | ||
Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. | Q33865906 | ||
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt | Q34093173 | ||
Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study | Q34134945 | ||
Hepatitis C in Pakistan: a review of available data. | Q34151617 | ||
Global distribution and prevalence of hepatitis C virus genotypes | Q34431175 | ||
Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran | Q34521691 | ||
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 | Q34533596 | ||
Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa | Q34761973 | ||
Hepatitis C virus: the burden of the disease. | Q34766939 | ||
Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications | Q34806261 | ||
An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt | Q34903996 | ||
Evaluation of prevalence and risk factors of hepatitis g virus infection among hemodialysis patients referred to Iranian army hospitals in tehran during 2012-2013. | Q35089905 | ||
Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt | Q35194411 | ||
Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan | Q35199494 | ||
Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran. | Q35226037 | ||
Sequencing and Phylogenetic Study of Partial NS3 Gene of Iranian GB Virus C/Hepatitis G Virus (HGV) Originated From Hemodialysis Patients in Tehran. | Q35232622 | ||
Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran | Q35457825 | ||
Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users | Q35507204 | ||
HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. | Q37345919 | ||
Sexual Transmission of Hepatitis C Virus Between HIV Infected Subjects and Their Main Heterosexual Partners. | Q37383351 | ||
Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011) | Q37401154 | ||
Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran. | Q37444193 | ||
Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients | Q37448517 | ||
Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence | Q37467821 | ||
Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran | Q37470458 | ||
Seven Years Trends in Prevalence of Transfusion-Transmissible Viral Infections in Yazd blood Transfusion Organization | Q37579277 | ||
Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran | Q37632074 | ||
Epidemiology of HIV infection in the Middle East and North Africa | Q37770840 | ||
Epidemiology of hepatitis C in the Middle East | Q37825369 | ||
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel | Q37886280 | ||
The prevalence rate of hepatitis B and hepatitis C co-infection in HIV positive patients in Mazandaran province, Iran. | Q50916693 | ||
The relationship between lichen planus and hepatitis C in dermatology outpatients in Kerman, Iran. | Q51842572 | ||
An overview analysis of blood donation in the Islamic Republic of Iran. | Q53234548 | ||
A mathematical theory of communication | Q56580111 | ||
Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa | Q57706414 | ||
[A preliminary study of HCV infections with hemophilia and their family members] | Q71665753 | ||
Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran | Q74664390 | ||
Infectious complications after kidney transplantation: a single-center experience | Q80355036 | ||
Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in tehran: preliminary report from "the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients" project | Q80694284 | ||
Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures | Q83873262 | ||
Risk factors of viral hepatitis: yet to explore | Q84713492 | ||
A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2014: The 49th Annual Meeting of the European Association for the Study of the Liver • April 9-13, 2014 • London, United KingdomSpecial Reporting on | Q85608080 | ||
Evaluation of new cases of HCV infection in thalassaemia patients for source of infection | Q41850011 | ||
A re-evaluation of random-effects meta-analysis. | Q41866179 | ||
Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients. | Q42199922 | ||
High prevalence of HCV coinfection in HIV-infected individuals in Shiraz, Islamic Republic of Iran | Q42227974 | ||
Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran | Q42252386 | ||
Seroprevalence of hepatitis C infection and associated risk factors among addicted prisoners in Sari-Iran. | Q42641251 | ||
Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. | Q42661108 | ||
High prevalence of hepatitis C infection among high risk groups in Kohgiloyeh and Boyerahmad Province, Southwest Iran. | Q42979528 | ||
Scope of worldwide hepatitis C problem | Q42980924 | ||
Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran. | Q42983398 | ||
Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran | Q42989142 | ||
Distribution of hepatitis C virus genotypes amongst the beta-thalassemia patients in North of Iran | Q42997191 | ||
Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study | Q43039669 | ||
Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht | Q43039971 | ||
Hepatitis G virus exposure in dialysis patients. | Q43040422 | ||
Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002. | Q44186522 | ||
Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). | Q44262990 | ||
Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors | Q44376231 | ||
Viral hepatitis and HIV infection among injection drug users in a central Iranian City | Q44579586 | ||
The incidence of hepatitis C in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study | Q44775481 | ||
Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals | Q45039831 | ||
Frequency and associated factors of proteinuria in Iranian HIV-positive patients. | Q45047158 | ||
Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors | Q45245806 | ||
Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. | Q45365382 | ||
Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran | Q45374830 | ||
Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran | Q45382290 | ||
Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. | Q45383598 | ||
Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals | Q45385144 | ||
Prevalence of hepatitis C virus infection in hemodialysis patients. | Q45395423 | ||
Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. | Q45397876 | ||
Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran | Q45400111 | ||
Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. | Q45401302 | ||
Serum Antibodies against Hepatitis C Virus in Iranian Patients with Graves' Disease | Q45407178 | ||
Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. | Q45410772 | ||
Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. | Q45733281 | ||
Inherited coagulation disorders in southern Iran. | Q45855987 | ||
Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease | Q45874158 | ||
Seroprevalence of HBsAg, anti-HCV, and anti-HIV among haemophiliac patients in Shiraz, Iran | Q45883554 | ||
Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran. | Q46255117 | ||
Behçet disease: clinical spectrum and association with hepatitis B and C viruses. | Q46987688 | ||
Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions | Q47548612 | ||
The impact of donor selection on blood safety in Iran | Q47874575 | ||
Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients | Q35507593 | ||
Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran | Q35603730 | ||
The association between oral lichen planus and hepatitis C virus infection; a report from northeast of iran | Q35667783 | ||
Study of the Associations Between TT Virus Single and Mixed Infections With Leukemia | Q35667788 | ||
Prevalence of Hepatitis G Virus Among Hemodialysis and Kidney Transplant Patients in Khuzestan Province, Iran | Q35690924 | ||
Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: seroprevalence and associated factors. | Q35714976 | ||
Intravenous drug use and hepatitis C virus in iran | Q35819891 | ||
Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran | Q35819898 | ||
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran | Q35851167 | ||
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa | Q35970414 | ||
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 | Q36035889 | ||
Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study | Q36054111 | ||
Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran | Q36075061 | ||
Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran | Q36101871 | ||
Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran | Q36101882 | ||
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran | Q36101899 | ||
Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran | Q36101954 | ||
Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran | Q36124943 | ||
Risk of hepatitis B and C infections in Tehranian wrestlers | Q36164428 | ||
Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors | Q36182327 | ||
Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. | Q36220214 | ||
Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013 | Q36221999 | ||
The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients | Q36270211 | ||
Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. | Q36315814 | ||
Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study | Q36329361 | ||
Distribution of hepatitis C virus genotypes in Iranian chronic infected patients | Q36638642 | ||
Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran | Q36730756 | ||
Seroprevalence of hepatitis C, hepatitis B and HIV viruses in hemophiliacs born 1985-2010 in west Azarbaijan of Iran | Q36732691 | ||
The prevalence of hepatitis C virus in mashhad, iran: a population-based study. | Q36893452 | ||
Hepatitis C Virus Infection in HIV Positive Attendees of Shiraz Behavioral Diseases Consultation Center in Southern Iran. | Q37023473 | ||
Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment | Q37097128 | ||
Health related quality of life in Iranian hemodialysis patients with viral hepatitis: changing epidemiology | Q37158709 | ||
Hepatitis B and C in dialysis units in Iran: changing the epidemiology. | Q37220215 | ||
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes | Q37261934 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Iran | Q794 |
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
Hepacivirus | Q2082778 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 150 | |
P577 | publication date | 2018-01-09 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses | |
P478 | volume | 8 |
Q90106891 | Characterization of the hepatitis C virus epidemic in Pakistan |
Q47548612 | Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions |
Q90259305 | Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran |
Q41921995 | Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions |
Q92151359 | Evaluation of the effectiveness of a pilot study of hospital-based hepatitis C epidemic surveillance |
Q64057534 | First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan |
Q38607430 | Hepatitis C Virus Genotypes in the Middle East and North Africa: Distribution, Diversity, and Patterns |
Q91658051 | Hepatitis C Virus Infection in Populations With Liver-Related Diseases in the Middle East and North Africa |
Q45223604 | Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions |
Q90968521 | Living in the shadows of hepatitis |
Q64061834 | Prevalence and genetic diversity of HCV among HIV-1 infected individuals living in Ahvaz, Iran |
Q58762714 | Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with -Thalassemia Major in Northern West Bank, Palestine |
Q96133941 | Prevalence of hepatitis C virus among HIV-infected patients |
Q57055896 | Prevalence of hepatitis C virus among street children in Iran |
Q90149473 | Prevalence of hepatitis E virus in thalassemia patients with hepatitis C in Tehran, Iran |
Q91650627 | Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran |
Q58698247 | Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan |
Q91073954 | The challenges of hepatitis C management in Iran: A qualitative study with patients |
Q61796170 | The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses |
Q55130317 | The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses. |
Q89490700 | The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa |
Q63767002 | Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests |
Search more.